Sangamo Therapeutics, Inc
SGMOCIK 0001001233 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:Material rewriteFull-doc fallback
Full filing:tone -0.0002Δ+0.014526% similar+279/-1515 ¶
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Sangamo Therapeutics, Inc
| Name | Roles | Filings |
|---|---|---|
| McClung David Mark | Officer | 7 |
| Fontenot Jason D. | Officer | 6 |
| Jain Nikunj | Officer | 6 |
| Markels John | Director | 5 |
| Parker H Stewart | Director | 5 |
All filings
175 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|